Matches in DBpedia 2016-04 for { ?s ?p "The combination drug tegafur/gimeracil/oteracil (trade name Teysuno, and TS-1 in Japan), also known as S-1, is used for the treatment of advanced gastric cancer. It is labelled for use in combination with cisplatin in many European countries, and for head and neck cancer, colorectal cancer, non–small-cell lung, breast, pancreatic, and biliary tract cancers in several countries in Asia. It has not been approved by the FDA.It is also being developed for the treatment of hepatocellular carcinoma."@en }
Showing triples 1 to 2 of
2
with 100 triples per page.
- oteracil comment "The combination drug tegafur/gimeracil/oteracil (trade name Teysuno, and TS-1 in Japan), also known as S-1, is used for the treatment of advanced gastric cancer. It is labelled for use in combination with cisplatin in many European countries, and for head and neck cancer, colorectal cancer, non–small-cell lung, breast, pancreatic, and biliary tract cancers in several countries in Asia. It has not been approved by the FDA.It is also being developed for the treatment of hepatocellular carcinoma.".
- Q15410179 comment "The combination drug tegafur/gimeracil/oteracil (trade name Teysuno, and TS-1 in Japan), also known as S-1, is used for the treatment of advanced gastric cancer. It is labelled for use in combination with cisplatin in many European countries, and for head and neck cancer, colorectal cancer, non–small-cell lung, breast, pancreatic, and biliary tract cancers in several countries in Asia. It has not been approved by the FDA.It is also being developed for the treatment of hepatocellular carcinoma.".